Back to Treatments

Treatment

Recombinant Factor IX

1
Conditions
61
Trials
30K
Participants
68%
Average Safety

Condition Evidence

Hemophilia

61 trials · 30K participants

90% effectiveness · 68% safety
Recombinant Factor IX | DFDA